CA
FRLN
CHI Advisors’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $373K | Buy |
86,654
+64,988
| +300% | +$279K | 0.15% | 25 |
|
2023
Q2 | $55.9K | Sell |
21,666
-4,707,753
| -100% | -$12.1M | 0.02% | 25 |
|
2023
Q1 | $2.15M | Sell |
4,729,419
-85,000
| -2% | -$38.7K | 0.57% | 19 |
|
2022
Q4 | $2.29M | Hold |
4,814,419
| – | – | 0.61% | 17 |
|
2022
Q3 | $3.37M | Sell |
4,814,419
-47,900
| -1% | -$33.5K | 0.91% | 19 |
|
2022
Q2 | $4.23M | Hold |
4,862,319
| – | – | 1.62% | 13 |
|
2022
Q1 | $5.45M | Buy |
4,862,319
+2,985,930
| +159% | +$3.34M | 2.32% | 9 |
|
2021
Q4 | $3.72M | Buy |
1,876,389
+448,908
| +31% | +$889K | 1.23% | 16 |
|
2021
Q3 | $4.87M | Buy |
1,427,481
+47,638
| +3% | +$162K | 1.42% | 13 |
|
2021
Q2 | $11.2M | Sell |
1,379,843
-4,900
| -0.4% | -$39.9K | 2.62% | 11 |
|
2021
Q1 | $17M | Buy |
1,384,743
+23,679
| +2% | +$291K | 3.41% | 11 |
|
2020
Q4 | $24.9M | Buy |
1,361,064
+36,700
| +3% | +$670K | 7% | 6 |
|
2020
Q3 | $20.7M | Buy |
+1,324,364
| New | +$20.7M | 7.35% | 6 |
|